News early in last week was dominated by presentations at the American Society of Hematology (ASH) meeting. Among these was ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) adopted positive opinions for six biosimilar medicines ...

PwC forecasts a significant increase in pharma and biotech mergers and acquisitions in 2025, driven by regulatory changes ...

US drugmaker AbbVie is to acquire Nimble Therapeutics, a USA-based Roche spinout developing oral peptide treatments in the ...

Sino-American biotech BeiGene has announced it has entered into a global licensing agreement with China’s CSPC Zhongqi Pharmaceutical Technology for SYH2039, a novel methionine adenosyltransferase 2A ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended another batch medicines for approval at ...

ICER reports $815 million in unsupported price hikes among top US drugs, identifying five with unjustified increases. The ...

Italy-based CNS specialist Newron Pharmaceuticals has entered into a license agreement with EA Pharma, part of Japan’s Eisai, ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of ...

Nine months out from landing $35 million in seed funding, Relation has more news – a big pharma collaboration. The group has ...

US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief ...

Spanish plasma-based medicines producer Grifols has announced the execution of an agreement for a private placement of 1.3 ...